Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0162316 (
iron deficiency anemia
)
3,806
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Long non-coding RNAs (lncRNAs) are transcripts longer than 200 nt that are involved in tumorigenesis and play a key role in cancer progression. To determine whether lncRNAs are involved in acute myeloid leukemia (AML), we analyzed the expression profile of lncRNAs and mRNAs in AML. Five pairs of AML patients and
iron deficiency anemia
(
IDA
) controls were screened by microarray. Through coexpression analysis, differently expressed transcripts were divided into modules, and lncRNAs were functionally annotated. We further analyzed the clinical significance of crucial lncRNAs from modules in public data. Finally, the expression of three lncRNAs,
RP11
-222K16.2, AC092580.4, and
RP11
-305O.6, were validated in newly diagnosed AML, AML relapse, and
IDA
patient groups by quantitative RT-PCR, which may be associated with AML patients' overall survival. Further analysis showed that
RP11
-222K16.2 might affect the differentiation of natural killer cells, and promote the immunized evasion of AML by regulating Eomesodermin expression. Analysis of this study revealed that dysregulated lncRNAs and mRNAs in AML vs
IDA
controls could affect the immune system and hematopoietic cell differentiation. The biological functions of those lncRNAs need to be further validated.
...
PMID:Expression profile analysis of long non-coding RNA in acute myeloid leukemia by microarray and bioinformatics. 2922 Jan 22